title: Treatment of chronic bullous disease of childhood.
abstract: Chronic bullous disease of childhood (CBDC) is generally a self-limited disease of prepubescent children that resolves within months to years. However, as discussed in the previous issue of Dermatologic Clinics, the disease is associated with significant morbidity and usually requires systemic therapy. Treatment is aimed at controlling blistering while avoiding adverse reactions. There are several anecdotal reports of treatment options, but controlled or comparative studies are lacking. This article discusses the management options of CBDC in more detail.
authors.affiliation: Department of Dermatology, Columbia University, 161 Fort Washington Avenue, 12th Floor, New York, NY 10032, USA.
authors.forename: Emily M
authors.initials: EM
authors.lastname: Mintz
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Morel
mesh_terms: D002648:Child; D002908:Chronic Disease; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents; D007070:Immunoglobulin A; D007166:Immunosuppressive Agents